Why Exhibit | CPhI South East Asia

Increase your brand awareness: Show them the way

By exhibiting at CPhI South East Asia your brand will be made visible to over 5,000 attendees and 260 other exhibitors all in one place. Your business will also be visible to over 500 unique visitors per month on our website on the CPhI South East Asia Exhibitor List.

 

South East Asia Market Overview

  1. Governments across Southeast Asia are introducing universal healthcare programs. This is driving rising demand for all categories of medicines, especially generic drugs. Since launching its mandatory healthcare coverage program (JKN) in 2014, Indonesia’s government healthcare spending has increased by 4%, and is forecast to reach USD 7.8 billion in 2016.
     
  2. Implementation of the ASEAN Economic Community (AEC) will open up greater opportunities for trade and commerce among its member states. Healthcare, including pharmaceuticals, has been identified as a key sector where efforts to achieve harmonization of laws and standards will be concentrated.
     
  3. Indonesia imports over 90% of the pharmaceutical ingredients it uses. The value of imports during the first half of 2015 saw a staggering rise of 17%, to USD 296 million.

 

south_east_asia

Four key trends that reshape the industry

Kalbe Farma And Kimia Farma To Open Raw Materials Plants In Indonesia

JAKARTA, Indonesia, Jan. 5, 2016 /PRNewswire/ -- Vidjongtius, director of Indonesia's largest pharmaceutical company, Kalbe Farma, stated that raw material import is a big challenge for the local pharmacy industry. As a response, he declared, Kalbe Farma is currently constructing a biopharmacy raw material manufacturing plant in Cikarang, West Java, scheduled to commercially commence operations in late 2017 or 2018.

Indonesian Pharma to Lobby for Foreign Direct Investments Incentives

Representatives of the Indonesian Pharma Industry declared that the government must offer incentives and widen the door to foreign direct investment in the country's pharmaceutical industry to reduce dependence on imported raw material for medicine. Meanwhile, in a bid to encourage the industry, the Investment Coordinating Board (BKPM) gauged a plan to allow foreign investors to hold more shares in pharmacy companies, from currently a maximum of 85 percent, to 100 percent

India Country Focus at Pharmaceutical Exhibition in Jakarta

Local and multinational drug makers will continue to see strong revenue growth from the Asia Pacific markets. The key factors being the sustained expansion of private healthcare, improving healthcare access and the sale of higher value medicines. In addition, the APAC region remains highly vulnerable to disease outbreaks which will serve as a driver for pharmaceutical products such as vaccines and medical devices.

Pharma Packaging in Indonesia: helping in the fight against counterfeits

According to the Indonesian Packaging Federation (FPI) the pharmaceutical industry is of overwhelming importance for Indonesia's packaging market, second only to the food and beverage industry. Noting the sheer size of this sector, hi-quality, sophisticated packaging is increasingly needed in the region in the fight against counterfeited pharma products.

To book your stand please contact:

The Sales Operation Team
Email: salesoperations@ubm.com 

Ms. Maria Lioe
Event Director
Tel.: +62 816 1847611
Email: maria.lioe@ubm.com